Sign in / Join Now
ETFs & Funds
Applying for Orphan Drug Status to Market Pancreatic Cancer Treatment Without Competition
Thanks for sharing. Here is link -
Based on their market numbers they shouldn't have a problem getting Orphan status in the US or EU
Add a reply...
Latest StockTalks »
people get PMCB breaking news and analysis by email alert.
Get email alerts on PMCB »
PharmaCyte Biotech, Inc.
Get latest price
From other sites
PharmaCyte's CEO Discusses Development Of Its Pancreatic Cancer Therapy
at TheStreet (Sep 15, 2016)
PharmaCyte Biotech Reports On Progress In Its Medical Cannabis Program
at TheStreet (Sep 1, 2016)
Dr. Mark L. Rabe Presents PharmaCyte Biotech's Ongoing Research At Cannabis Cancer Forum
at TheStreet (Aug 2, 2016)
PharmaCyte Executives Meet With Translational Drug Development to Advance Pancreatic Cancer Clinical Trial
at 4-traders.com (Jan 25, 2016)
Pharmacyte Biotech : Contractor Chamow & Associates to Visit Cell-in-a-Box Encapsulation Facility in Bangkok, Thailand
at 4-traders.com (Dec 5, 2015)